The test detects mutations across 46 genes in cancer cells, mutations which may be driving the growth of the cancer in patients with solid tumours. The presence of a mutation in a gene can potentially determine which treatment a patient should receive.
46 gene sequencing test for cancer patients on the NHS
27 March 2013
The first multi-gene test that can help predict cancer patients' responses to treatment using the latest DNA sequencing techniques has been launched in the NHS, thanks to a partnership between scientists at the University of Oxford and Oxford University Hospitals NHS Trust.